The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Complement System Part II: Role in Immunity
Open accessAbstract
The complement system has been considered for a long time as a simple lytic cascade, aimed to kill bacteria infecting the host organism. Nowadays, this vision has changed and it is well accepted that complement is a complex innate immune surveillance system, playing a key role in host homeostasis, inflammation, and in the defense against pathogens. This review discusses recent advances in the understanding of the role of complement in physiology and pathology. It starts with a description of complement contribution to the normal physiology (homeostasis) of a healthy organism, including the silent clearance of apoptotic cells and maintenance of cell survival. In pathology, complement can be a friend or a foe. It acts as a friend in the defense against pathogens, by inducing opsonization and a direct killing by C5b-9 membrane attack complex and by triggering inflammatory responses with the anaphylatoxins C3a and C5a. Opsonization plays also a major role in the mounting of an adaptive immune response, involving antigen presenting cells, T-, and B-lymphocytes. Nevertheless, it can be also an enemy, when pathogens hijack complement regulators to protect themselves from the immune system. Inadequate complement activation becomes a disease cause, as in atypical hemolytic uremic syndrome, C3 glomerulopathies, and systemic lupus erythematosus. Age-related macular degeneration and cancer will be described as examples showing that complement contributes to a large variety of conditions, far exceeding the classical examples of diseases associated with complement deficiencies. Finally, we discuss complement as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 1×
“The complement system plays a major role in the tolerogenic perception of apoptosis, which is in partmediated by opsonization with C1q and iC3b and subsequent clearance of dying cells (4, 5) (Figure 2B).”
BackgroundClassification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399 · cited 1×
“Among these modifications, a major one is the expression of phosphatidylserine (PS) on the external side of the cell membrane, which is normally sequestered in the inner surface of the cell membrane (3).”
BackgroundMechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Complement and its role in innate and adaptive immune responses
Dunkelberger, J. R., & Song, W.-C. (2010) · Cell Research · doi:10.1038/cr.2009.139 · Cited by 1,932
Age-related macular degeneration
Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60282-7 · Cited by 1,717
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Self-citationWalport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441506 · Cited by 1,481
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
Sadler, J. E. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.395 · Cited by 1,363
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Hillmen, P., Young, N. S., Schubert, J., Brodsky, R. A., Socié, G., Muus, P., Röth, A., Szer, J., Elebute, M. O., Nakamura, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061648 · Cited by 1,303
LeVine, A. M., Kurak, K. E., Wright, J. R., Watford, W. T., Bruno, M. D., Ross, G. F., Whitsett, J. A., & Korfhagen, T. R. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.2.3303 · Cited by 1,273
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
Ogden, C. A., deCathelineau, A., Hoffmann, P. R., Bratton, D., Ghebrehiwet, B., Fadok, V. A., & Henson, P. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.781 · Cited by 1,147
Noris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02210310 · Cited by 1,042
Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling
Kagan, J. C., & Medzhitov, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.047 · Cited by 847
DeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 822
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730 · cited 5×
“C3a and C5a are able to induce potent inflammatory pathways via their receptors C3aR and C5aR.”
BackgroundInfluentialComplement evasion by human pathogens
Lambris, J. D., Ricklin, D., & Geisbrecht, B. V. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1824 · Cited by 722
Fremeaux-Bacchi, V., Fakhouri, F., Garnier, A., Bienaimé, F., Dragon-Durey, M.-A., Ngo, S., Moulin, B., Servais, A., Provot, F., Rostaing, L., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04760512 · Cited by 714
Self-citationComplement-dependent Clearance of Apoptotic Cells by Human Macrophages
Mevorach, D., Mascarenhas, J. O., Gershov, D., & Elkon, K. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2313 · Cited by 700
The chemotactic receptor for human C5a anaphylatoxin
Gerard, N. P., & Gerard, C. (1991) · Nature · doi:10.1038/349614a0 · Cited by 655
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
Kemper, C., Chan, A. C., Green, J. M., Brett, K. A., Murphy, K. M., & Atkinson, J. P. (2003) · Nature · doi:10.1038/nature01315 · Cited by 587
Liszewski, M. K., Kolev, M., Le Friec, G., Leung, M., Bertram, P. G., Fara, A. F., Subias, M., Pickering, M. C., Drouet, C., Meri, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.018 · Cited by 582
Strainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., Shapiro, V. S., Dubyak, G. R., Heeger, P. S., & Medof, M. E. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.001 · Cited by 580
Servais, A., Noël, L.-H., Roumenina, L. T., Le Quintrec, M., Ngo, S., Dragon-Durey, M.-A., Macher, M.-A., Zuber, J., Karras, A., Provot, F., et al. (2012) · Kidney International · doi:10.1038/ki.2012.63 · Cited by 575
Self-citationMembranoproliferative Glomerulonephritis — A New Look at an Old Entity
Sethi, S., & Fervenza, F. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108178 · Cited by 565
Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis
Pickering, M. C., Botto, M., Taylor, P. R., Lachmann, P. J., & Walport, M. J. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76021-x · Cited by 544
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., et al. (2011) · Nature · doi:10.1038/nature10449 · Cited by 533 · cited 2×
“At risk, FH variant H402 has a weaker capacity to interact with oxidized lipids and malondialdehyde in the drusen, thus allowing constant background complement activation, leading to retinal epithelial cells damage and macrophages activation (249, 250).”
BackgroundAnti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
on behalf of the French Study Group for aHUS/C3G, Zuber, J., Fakhouri, F., Roumenina, L. T., Loirat, C., & Frémeaux-Bacchi, V. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.214 · Cited by 496
Self-citationRecessive mutations in DGKE cause atypical hemolytic-uremic syndrome
Lemaire, M., Frémeaux-Bacchi, V., Schaefer, F., Choi, M., Tang, W. H., Le Quintrec, M., Fakhouri, F., Taque, S., Nobili, F., Martinez, F., et al. (2013) · Nature Genetics · doi:10.1038/ng.2590 · Cited by 483
Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
Hughes, A. E., Orr, N., Esfandiary, H., Diaz-Torres, M., Goodship, T., & Chakravarthy, U. (2006) · Nature Genetics · doi:10.1038/ng1890 · Cited by 467
de Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Bonavita, E., Gentile, S., Rubino, M., Maina, V., Papait, R., Kunderfranco, P., Greco, C., Feruglio, F., Molgora, M., Laface, I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.004 · Cited by 417
Protective effects of C5a blockade in sepsis
Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., & Ward, P. A. (1999) · Nature Medicine · doi:10.1038/10512 · Cited by 404
Platelet activation leads to activation and propagation of the complement system
del Conde, I., Crúz, M. A., Zhang, H., López, J. A., & Afshar-Kharghan, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041497 · Cited by 397
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects
Morgan, B. P. (1989) · Biochemical Journal · doi:10.1042/bj2640001 · Cited by 380
Regulation of Toll-like receptor–mediated inflammatory response by complement in vivo
Zhang, X., Kimura, Y., Fang, C., Zhou, L., Sfyroera, G., Lambris, J. D., Wetsel, R. A., Miwa, T., & Song, W.-C. (2007) · Blood · doi:10.1182/blood-2006-12-063636 · Cited by 373
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Frémeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain, L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133702 · Cited by 372
C3 glomerulopathy: a new classification
Fakhouri, F., Frémeaux-Bacchi, V., Noël, L.-H., Cook, H. T., & Pickering, M. C. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.85 · Cited by 363
ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO
Pepys, M. B. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.140.1.126 · Cited by 356
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Józsi, M., Licht, C., Strobel, S., Zipfel, S. L. H., Richter, H., Heinen, S., Zipfel, P. F., & Skerka, C. (2008) · Blood · doi:10.1182/blood-2007-09-109876 · Cited by 354
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
The European Paediatric Study Group for HUS, Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C., Loirat, C., Pecoraro, C., Taylor, C. M., et al. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-0964-1 · Cited by 352
Bresin, E., Rurali, E., Caprioli, J., Sanchez-Corral, P., Fremeaux-Bacchi, V., Rodriguez de Cordoba, S., Pinto, S., Goodship, T. H. J., Alberti, M., Ribes, D., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090884 · Cited by 352
Self-citationManuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Seddon, J. M., Yu, Y., Miller, E. C., Reynolds, R., Tan, P. L., Gowrisankar, S., Goldstein, J. I., Triebwasser, M., Anderson, H. E., Zerbib, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2741 · Cited by 346
T-cell regulation: with complements from innate immunity
Kemper, C., & Atkinson, J. P. (2007) · Nature Reviews Immunology · doi:10.1038/nri1994 · Cited by 340
C3a and C5a Stimulate Chemotaxis of Human Mast Cells
Hartmann, K., Henz, B. M., Krüger-Krasagakes, S., Köhl, J., Burger, R., Guhl, S., Haase, I., Lippert, U., & Zuberbier, T. (1997) · Blood · doi:10.1182/blood.v89.8.2863 · Cited by 331
Longhurst, H., & Cicardi, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60935-5 · Cited by 330
Gale, D. P., de Jorge, E. G., Cook, H. T., Martinez-Barricarte, R., Hadjisavvas, A., McLean, A. G., Pusey, C. D., Pierides, A., Kyriacou, K., Athanasiou, Y., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60670-8 · Cited by 327
Fang, Y., Xu, C., Fu, Y.-X., Holers, V. M., & Molina, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5273 · Cited by 320
Morelli, A. E., Larregina, A. T., Shufesky, W. J., Zahorchak, A. F., Logar, A. J., Papworth, G. D., Wang, Z., Watkins, S. C., Falo, L. D., & Thomson, A. W. (2003) · Blood · doi:10.1182/blood-2002-06-1769 · Cited by 314
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Schneider, M. C., Prosser, B. E., Caesar, J. J. E., Kugelberg, E., Li, S., Zhang, Q., Quoraishi, S., Lovett, J. E., Deane, J. E., Sim, R. B., et al. (2009) · Nature · doi:10.1038/nature07769 · Cited by 314
Asgari, E., Le Friec, G., Yamamoto, H., Perucha, E., Sacks, S. S., Köhl, J., Cook, H. T., & Kemper, C. (2013) · Blood · doi:10.1182/blood-2013-05-502229 · Cited by 310
Strainic, M. G., Shevach, E. M., An, F., Lin, F., & Medof, M. E. (2013) · Nature Immunology · doi:10.1038/ni.2499 · Cited by 302
Tosi, M. F., Zakem, H., & Berger, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114699 · Cited by 289
Dimerization of complement factor H-related proteins modulates complement activation in vivo
Goicoechea de Jorge, E., Caesar, J. J. E., Malik, T. H., Patel, M., Colledge, M., Johnson, S., Hakobyan, S., Morgan, B. P., Harris, C. L., Pickering, M. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219260110 · Cited by 289
ROSS, G. D., & VĚTVIČKA, V (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03377.x · Cited by 286
Decay-accelerating factor modulates induction of T cell immunity
Heeger, P. S., Lalli, P. N., Lin, F., Valujskikh, A., Liu, J., Muqim, N., Xu, Y., & Medof, M. E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041967 · Cited by 286
Coulthard, L. G., & Woodruff, T. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403068 · Cited by 285
Cardone, J., Le Friec, G., Vantourout, P., Roberts, A., Fuchs, A., Jackson, I., Suddason, T., Lord, G., Atkinson, J. P., Cope, A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1917 · Cited by 284
Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
Corrales, L., Ajona, D., Rafail, S., Lasarte, J. J., Riezu-Boj, J. I., Lambris, J. D., Rouzaut, A., Pajares, M. J., Montuenga, L. M., & Pio, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201654 · Cited by 281
Daffern, P. J., Pfeifer, P. H., Ember, J. A., & Hugli, T. E. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2119 · Cited by 281
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Hawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C., & Köhl, J. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.006 · Cited by 276
Païdassi, H., Tacnet-Delorme, P., Garlatti, V., Darnault, C., Ghebrehiwet, B., Gaboriaud, C., Arlaud, G. J., & Frachet, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2329 · Cited by 270
The complement system in systemic lupus erythematosus: an update
Leffler, J., Bengtsson, A. A., & Blom, A. M. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205287 · Cited by 265
Complement factor H related proteins (CFHRs)
Skerka, C., Chen, Q., Fremeaux-Bacchi, V., & Roumenina, L. T. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.06.001 · Cited by 264
Self-citationKlos, A., Wende, E., Wareham, K. J., & Monk, P. N. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005223 · Cited by 264
Verbovetski, I., Bychkov, H., Trahtemberg, U., Shapira, I., Hareuveni, M., Ben-Tal, O., Kutikov, I., Gill, O., & Mevorach, D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020263 · Cited by 262
C5L2, a Nonsignaling C5A Binding Protein
Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M., Krause, J. E., Choe, H.-R., Gerard, N. P., et al. (2003) · Biochemistry · doi:10.1021/bi034489v · Cited by 261
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
Liu, J., Miwa, T., Hilliard, B., Chen, Y., Lambris, J. D., Wells, A. D., & Song, W.-C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040863 · Cited by 252
The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
Bamberg, C. E., Mackay, C. R., Lee, H., Zahra, D., Jackson, J., Lim, Y. S., Whitfeld, P. L., Craig, S., Corsini, E., Lu, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092106 · Cited by 249
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome
Frimat, M., Tabarin, F., Dimitrov, J. D., Poitou, C., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2013) · Blood · doi:10.1182/blood-2013-03-489245 · Cited by 249
Self-citationStructure and activation of the C1 complex of complement: unraveling the puzzle
Gaboriaud, C., Thielens, N. M., Gregory, L. A., Rossi, V., Fontecilla-Camps, J. C., & Arlaud, G. J. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.008 · Cited by 247
Neutrophil β2 integrins: moderators of life or death decisions
Mayadas, T. N., & Cullere, X. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.05.002 · Cited by 247
Benoit, M. E., Clarke, E. V., Morgado, P., Fraser, D. A., & Tenner, A. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103760 · Cited by 246
Cain, S. A., & Monk, P. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100714200 · Cited by 245
Trouw, L. A., Groeneveld, T. W. L., Seelen, M. A., Duijs, J. M. G. J., Bajema, I. M., Prins, F. A., Kishore, U., Salant, D. J., Verbeek, J. S., Kooten, C. V., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421075 · Cited by 245
Integrin-dependent phagocytosis – spreading from microadhesion to new concepts
Dupuy, A. G., & Caron, E. (2008) · Journal of Cell Science · doi:10.1242/jcs.018036 · Cited by 244
C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
Chen, N.-J., Mirtsos, C., Suh, D., Lu, Y.-C., Lin, W.-J., McKerlie, C., Lee, T., Baribault, H., Tian, H., & Yeh, W.-C. (2007) · Nature · doi:10.1038/nature05559 · Cited by 243
Anti-opsonic properties of staphylokinase
Rooijakkers, S. H. M., van Wamel, W. J. B., Ruyken, M., van Kessel, K. P. M., & van Strijp, J. A. G. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2004.12.014 · Cited by 237
Morigi, M., Galbusera, M., Gastoldi, S., Locatelli, M., Buelli, S., Pezzotta, A., Pagani, C., Noris, M., Gobbi, M., Stravalaci, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100491 · Cited by 235
Staphylococcal complement evasion by various convertase-blocking molecules
Jongerius, I., Köhl, J., Pandey, M. K., Ruyken, M., van Kessel, K. P. M., van Strijp, J. A. G., & Rooijakkers, S. H. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070818 · Cited by 233
Verhoef, G., Johnsen, H. E., Rossi, F. G., Salar, A., Hamilton, L., Schoonen, W. M., Pujol, B., & Duhrsen, U. (2008) · Blood · doi:10.1182/blood.v112.11.4948.4948 · Cited by 233
Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
Matsumoto, A. K., Martin, D. R., Carter, R. H., Klickstein, L. B., Ahearn, J. M., & Fearon, D. T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1407 · Cited by 231
Functional Significance of Factor H Binding to Neisseria meningitidis
Schneider, M. C., Exley, R. M., Chan, H., Feavers, I., Kang, Y.-H., Sim, R. B., & Tang, C. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7566 · Cited by 230
Complement Peptides C3a- and C5a-Induced Mediator Release from Dissociated Human Skin Mast Cells
El-Lati, S. G., Church, M. K., & Dahinden, C. A. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12378589 · Cited by 228
Meningococcal disease and the complement system
Lewis, L. A., & Ram, S. (2014) · Virulence · doi:10.4161/viru.26515 · Cited by 227
Rooijakkers, S. H. M., Wu, J., Ruyken, M., van Domselaar, R., Planken, K. L., Tzekou, A., Ricklin, D., Lambris, J. D., Janssen, B. J. C., van Strijp, J. A. G., et al. (2009) · Nature Immunology · doi:10.1038/ni.1756 · Cited by 225
Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N
Campbell, W. D., Lazoura, E., Okada, N., & Okada, H. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02669.x · Cited by 224
Martínez-Barricarte, R., Heurich, M., Valdes-Cañedo, F., Vazquez-Martul, E., Torreira, E., Montes, T., Tortajada, A., Pinto, S., Lopez-Trascasa, M., Morgan, B. P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43343 · Cited by 222
Autocrine Effects of Tumor-Derived Complement
Cho, M. S., Vasquez, H. G., Rupaimoole, R., Pradeep, S., Wu, S., Zand, B., Han, H.-D., Rodriguez-Aguayo, C., Bottsford-Miller, J., Huang, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.014 · Cited by 219
Staphylococcus aureus Metalloprotease Aureolysin Cleaves Complement C3 To Mediate Immune Evasion
Laarman, A. J., Ruyken, M., Malone, C. L., van Strijp, J. A. G., Horswill, A. R., & Rooijakkers, S. H. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002948 · Cited by 216
Kwan, W.-H., van der Touw, W., Paz-Artal, E., Li, M. O., & Heeger, P. S. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121525 · Cited by 215 · cited 1×
“The absence of C3aR and C5aR stimulation during T cell activation induces Treg development (145, 146).”
BackgroundHuman T Cells Express the C5a Receptor and Are Chemoattracted to C5a
Nataf, S., Davoust, N., Ames, R. S., & Barnum, S. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4018 · Cited by 214
Complement: central to innate immunity and bridging to adaptive responses
Morgan, B. P., Marchbank, K. J., Longhi, M. P., Harris, C. L., & Gallimore, A. M. (2005) · Immunology Letters · doi:10.1016/j.imlet.2004.11.010 · Cited by 213
A new biologic role for C3a and C3a desArg: regulation of TNF-α and IL-1 β synthesis
Takabayashi, T., Vannier, E., Clark, B. D., Margolis, N. H., Dinarello, C. A., Burke, J. F., & Gelfand, J. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3455 · Cited by 207
Rooijakkers, S. H. M., & van Strijp, J. A. G. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.011 · Cited by 207
Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention
Mastellos, D. C., Yancopoulou, D., Kokkinos, P., Huber‐Lang, M., Hajishengallis, G., Biglarnia, A. R., Lupu, F., Nilsson, B., Risitano, A. M., Ricklin, D., et al. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12419 · Cited by 206
The CD46-Jagged1 interaction is critical for human TH1 immunity
Le Friec, G., Sheppard, D., Whiteman, P., Karsten, C. M., Shamoun, S. A.-T., Laing, A., Bugeon, L., Dallman, M. J., Melchionna, T., Chillakuri, C., et al. (2012) · Nature Immunology · doi:10.1038/ni.2454 · Cited by 204
Self-citationFritsche, L. G., Lauer, N., Hartmann, A., Stippa, S., Keilhauer, C. N., Oppermann, M., Pandey, M. K., Köhl, J., Zipfel, P. F., Weber, B. H. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq399 · Cited by 203
Campbell, D. G., Gagnon, J., Reid, K. B., & Williams, A. F. (1981) · Biochemical Journal · doi:10.1042/bj1950015 · Cited by 202
An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2
Gerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S., & Gerard, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500287200 · Cited by 201
Vadrevu, S. K., Chintala, N. K., Sharma, S. K., Sharma, P., Cleveland, C., Riediger, L., Manne, S., Fairlie, D. P., Gorczyca, W., Almanza, O., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0157 · Cited by 199
C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation
Tortajada, A., Yébenes, H., Abarrategui-Garrido, C., Anter, J., García-Fernández, J. M., Martínez-Barricarte, R., Alba-Domínguez, M., Malik, T. H., Bedoya, R., Pérez, R. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68280 · Cited by 197
Beyond lysis: how complement influences cell fate
COLE, D. S., & MORGAN, B. P. (2003) · Clinical Science · doi:10.1042/cs20020362 · Cited by 195
Structural and functional anatomy of the globular domain of complement protein C1q
Kishore, U., Ghai, R., Greenhough, T. J., Shrive, A. K., Bonifati, D. M., Gadjeva, M. G., Waters, P., Kojouharova, M. S., Chakraborty, T., & Agrawal, A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.015 · Cited by 195
Risitano, A. M., Ricklin, D., Huang, Y., Reis, E. S., Chen, H., Ricci, P., Lin, Z., Pascariello, C., Raia, M., Sica, M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536573 · Cited by 194
Bienaime, F., Dragon-Durey, M.-A., Regnier, C. H., Nilsson, S. C., Kwan, W. H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M.-A., Loirat, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.472 · Cited by 192
Self-citationIntracellular sensing of complement C3 activates cell autonomous immunity
Tam, J. C. H., Bidgood, S. R., McEwan, W. A., & James, L. C. (2014) · Science · doi:10.1126/science.1256070 · Cited by 189
Causes of Alternative Pathway Dysregulation in Dense Deposit Disease
Zhang, Y., Meyer, N. C., Wang, K., Nishimura, C., Frees, K., Jones, M., Katz, L. M., Sethi, S., & Smith, R. J. H. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07900811 · Cited by 188
Carboxypeptidase N: a pleiotropic regulator of inflammation
Matthews, K. W., Mueller-Ortiz, S. L., & Wetsel, R. A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.002 · Cited by 185
Cherukuri, A., Cheng, P. C., & Pierce, S. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.163 · Cited by 181
Surace, L., Lysenko, V., Fontana, A. O., Cecconi, V., Janssen, H., Bicvic, A., Okoniewski, M., Pruschy, M., Dummer, R., Neefjes, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.009 · Cited by 179
Complement evasion of pathogens: Common strategies are shared by diverse organisms
Zipfel, P. F., Würzner, R., & Skerka, C. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.149 · Cited by 176
Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U‐937 cells
Crass, T., Raffetseder, U., Martin, U., Grove, M., Klos, A., Köhl, J., & Bautsch, W. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260840 · Cited by 174
Lachmann, P. J., & Halbwachs‐Mecarelli, L. (1975) · PubMed · Cited by 173
Self-citationFerreira, V. P., Herbert, A. P., Cortés, C., McKee, K. A., Blaum, B. S., Esswein, S. T., Uhrín, D., Barlow, P. N., Pangburn, M. K., & Kavanagh, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804031 · Cited by 173
Peng, Q., Li, K., Anderson, K., Farrar, C. A., Lu, B., Smith, R. A. G., Sacks, S. H., & Zhou, W. (2008) · Blood · doi:10.1182/blood-2007-06-095018 · Cited by 173
Elsner, J., Oppermann, M., Czech, W., & Kapp, A. (1994) · Blood · doi:10.1182/blood.v83.11.3324.3324 · Cited by 170
Peng, Q., Li, K., Patel, H., Sacks, S. H., & Zhou, W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3330 · Cited by 169
Elsner, J., Oppermann, M., Czech, W., Dobos, G., Schöpf, E., Norgauer, J., & Kapp, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240304 · Cited by 167
Wu, M. C. L., Brennan, F. H., Lynch, J. P. L., Mantovani, S., Phipps, S., Wetsel, R. A., Ruitenberg, M. J., Taylor, S. M., & Woodruff, T. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218815110 · Cited by 165
Fraser, D. A., Laust, A. K., Nelson, E. L., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902232 · Cited by 163
Compstatin: A Complement Inhibitor on its Way to Clinical Application
Ricklin, D., & Lambris, J. D. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_20 · Cited by 162
Lewis, L. A., Ngampasutadol, J., Wallace, R., Reid, J. E. A., Vogel, U., & Ram, S. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001027 · Cited by 159
A structural basis for complement inhibition by Staphylococcus aureus
Hammel, M., Sfyroera, G., Ricklin, D., Magotti, P., Lambris, J. D., & Geisbrecht, B. V. (2007) · Nature Immunology · doi:10.1038/ni1450 · Cited by 159
Roumenina, L. T., Jablonski, M., Hue, C., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197640 · Cited by 157
Self-citationAlternative complement pathway assessment in patients with atypical HUS
Roumenina, L. T., Loirat, C., Dragon‐Durey, M., Halbwachs‐Mecarelli, L., Sautès‐Fridman, C., & Frémeaux‐Bacchi, V. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.020 · Cited by 157
Self-citationMutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome
Frémeaux‐Bacchi, V., Goodship, T. H. J., Régnier, C. H., Dragon‐Durey, M., Janssen, B. J. C., & Atkinson, J. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.038 · Cited by 153
Genetics of Atypical Hemolytic Uremic Syndrome (aHUS)
Hidalgo, M., Pinto, S., Tortajada, A., & de Córdoba, S. R. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1375296 · Cited by 149
Shaw, P. X., Zhang, L., Zhang, M., Du, H., Zhao, L., Lee, C., Grob, S., Lim, S. L., Hughes, G., Lee, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121309109 · Cited by 148
Morgan, B. P., & Campbell, A. K. (1985) · Biochemical Journal · doi:10.1042/bj2310205 · Cited by 146
Ngampasutadol, J., Ram, S., Gulati, S., Agarwal, S., Li, C., Visintin, A., Monks, B. G., Madico, G. E., & Rice, P. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3426 · Cited by 145
Schramm, E. C., Roumenina, L. T., Robe-Rybkine, T., Chauvet, S., Vieira-Martins, P., Hue, C., Maga, T., Valoti, E., Wilson, V., Jokiranta, S. T., et al. (2015) · Blood · doi:10.1182/blood-2014-10-609073 · Cited by 143
Self-citationA prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
Roumenina, L. T., Frimat, M., Miller, E. C., Provôt, F., Dragon‐Durey, M., Bordereau, P., Bigot, S., Hue, C., Satchell, S. C., Mathieson, P. W., et al. (2012) · Blood · doi:10.1182/blood-2011-10-383281 · Cited by 142
Self-citationRoles of phospholipase C β2 in chemoattractant-elicited responses
Jiang, H., Kuang, Y., Wu, Y., Xie, W., Simon, M. I., & Wu, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7971 · Cited by 142
Haupt, K., Reuter, M., van den Elsen, J. M. H., Burman, J. D., Hälbich, S., Richter, J., Skerka, C., & Zipfel, P. F. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000250 · Cited by 141
Inhibition of Complement Activation by a Secreted Staphylococcus aureus Protein
Lee, L. Y., Höök, M., Haviland, D. L., Wetsel, R. A., Yonter, E. O., Syribeys, P. J., Vernachio, J. H., & Brown, E. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/422259 · Cited by 139
Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting Properties
Schmidt, C. Q., Bai, H., Lin, Z., Risitano, A. M., Barlow, P. N., Ricklin, D., & Lambris, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203548 · Cited by 139
C4b-Binding Protein (C4BP) Activates B Cells through the CD40 Receptor
Brodeur, S. R., Angelini, F., Bacharier, L. B., Blom, A. M., Mizoguchi, E., Fujiwara, H., Plebani, A., Notarangelo, L. D., Dahlbäck, B., Tsitsikov, E. N., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00149-3 · Cited by 136
Nilsson, B., Larsson, R. L., Hong, J., Elgue, G., Ekdahl, K. N., Sahu, A., & Lambris, J. D. (1998) · Blood · doi:10.1182/blood.v92.5.1661 · Cited by 135
A Hybrid CFHR3-1 Gene Causes Familial C3 Glomerulopathy
Malik, T. H., Lavin, P., de Jorge, E. G., Vernon, K. A., Rose, K. L., Patel, M., de Leeuw, M. A., Neary, J. J., Conlon, P. J., Winn, M. P., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020166 · Cited by 135
Mapping of the C5a receptor signal transduction network in human neutrophils.
Buhl, A. M., Avdi, N. J., Worthen, G. S., & Johnson, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9190 · Cited by 132
Staphylococcal Proteases Aid in Evasion of the Human Complement System
Jusko, M., Potempa, J., Kantyka, T., Bielecka, E., Miller, H. K., Kalińska, M., Dubin, G., Garred, P., Shaw, L. N., & Blom, A. M. (2013) · Journal of Innate Immunity · doi:10.1159/000351458 · Cited by 132
Molecular mechanisms of complement evasion: learning from staphylococci and meningococci
Serruto, D., Rappuoli, R., Scarselli, M., Gros, P., & van Strijp, J. A. G. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2366 · Cited by 132
Expression of Complement Factor H by Lung Cancer Cells
Ajona, D., Castaño, Z., Garayoa, M., Zudaire, E., Pajares, M. J., Martínez, A., Cuttitta, F. F., Montuenga, L. M., & Pío, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2328 · Cited by 132
Venkatesha, R. T., Thangam, E. R. R. B., Zaidi, A. K., & Ali, H. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.009 · Cited by 131
Lee, L. Y., Liang, X., Höök, M., & Brown, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408570200 · Cited by 131
Harokopakis, E., Albzreh, M. H., Martin, M. H., & Hajishengallis, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7645 · Cited by 129
Fischer, W. H., & Hugli, T. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4279 · Cited by 128
Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.
Kinders, R. J., Jones, T., Root, R., Bruce, C. L., Murchison, H. A., Corey, M. J., Williams, L., Enfield, D. L., & Hass, G. M. (1998) · PubMed · Cited by 127
Risitano, A. M., Notaro, R., Pascariello, C., Sica, M., Vecchio, L. D., Horvath, C. J., Fridkis‐Hareli, M., Selleri, C., Lindorfer, M. A., Taylor, R. P., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398792 · Cited by 125
la Sala, A., Gadina, M., & Kelsall, B. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2994 · Cited by 123
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway
Perianayagam, M. C., Balakrishnan, V. S., King, A. J., Pereira, B. J. G., & Jaber, B. L. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00139.x · Cited by 123
Antibody Polyreactivity in Health and Disease: Statu Variabilis
Dimitrov, J. D., Planchais, C., Roumenina, L. T., Vassilev, T. L., Kaveri, S. V., & Lacroix‐Desmazes, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300880 · Cited by 122
Self-citationFridkis‐Hareli, M., Storek, M., Mazsaroff, I., Risitano, A. M., Lundberg, A. S., Horvath, C. J., & Holers, V. M. (2011) · Blood · doi:10.1182/blood-2011-06-359646 · Cited by 121
Fraga, T. R., Courrol, D. D. S., Valencia, M. M. C., Hirata, I. Y., Vasconcellos, S. A., Juliano, L., Barbosa, A. S., & Isaac, L. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit569 · Cited by 120
Johnson, S. A., Stojanović, J., Ariceta, G., Bitzan, M. M., Beşbaş, N., Frieling, M. L., Karpman, D., Landau, D., Langman, C. B., Licht, C. P. B., et al. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2817-4 · Cited by 120
Structural basis for activation of the complement system by component C4 cleavage
Kidmose, R. T., Laursen, N. S., Dobó, J., Kjær, T. R., Sirotkina, S., Yatime, L., Sottrup‐Jensen, L., Thiel, S., Gál, P., & Andersen, G. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208031109 · Cited by 119
C1q and phagocytosis: the perfect complement to a good meal
Galvan, M. D., Greenlee‐Wacker, M. C., & Bohlson, S. S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212099 · Cited by 119
Complement Factor B Mutations in Atypical Hemolytic Uremic Syndrome—Disease-Relevant or Benign?
Marinozzi, M. C., Vergoz, L., Robe-Rybkine, T., Ngo, S., Bettoni, S., Pashov, A. D., Cayla, M., Tabarin, F., Jablonski, M., Hue, C., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070796 · Cited by 116
Self-citationSharp, J. A., Echague, C. G., Hair, P. S., Ward, M. D., Nyalwidhe, J. O., Geoghegan, J. A., Foster, T. J., & Cunnion, K. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038407 · Cited by 116
Herpes Simplex Virus Type 1 Glycoprotein gC Mediates Immune Evasion In Vivo
Lubinski, J. M., Wang, L., Soulika, A. M., Bürger, R., Wetsel, R. A., Colten, H. R., Cohen, G. H., Eisenberg, R. J., Lambris, J. D., & Friedman, H. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8257-8263.1998 · Cited by 116
Toward a structure-based comprehension of the lectin pathway of complement
Kjær, T. R., Thiel, S., & Andersen, G. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.220 · Cited by 115
Microbes Bind Complement Inhibitor Factor H via a Common Site
Meri, T., Amdahl, H., Lehtinen, M. J., Hyvärinen, S., McDowell, J. V., Bhattacharjee, A., Meri, S., Marconi, R. T., Goldman, A., & Jokiranta, T. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003308 · Cited by 113
Complement factor H–related hybrid protein deregulates complement in dense deposit disease
Chen, Q., Wiesener, M. S., Eberhardt, H. U., Hartmann, A., Uzonyi, B., Kirschfink, M., Amann, K., Buettner, M., Goodship, T. H. J., Hugo, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71866 · Cited by 110
Schejbel, L., Skattum, L., Hagelberg, S., Åhlin, A., Schiller, B., Berg, S., Genel, F., Truedsson, L., & Garred, P. (2011) · Genes and Immunity · doi:10.1038/gene.2011.39 · Cited by 109
Novel roles of complement in T effector cell regulation
Heeger, P. S., & Kemper, C. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.004 · Cited by 109
Kinoshita, T., Takata, Y., Kozono, H., et al. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.11.3895 · Cited by 107
Païdassi, H., Tacnet‐Delorme, P., Verneret, M., Gaboriaud, C., Houen, G., Duus, K., Ling, W. L., Arlaud, G. J., & Frachet, P. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.02.029 · Cited by 105
Gál, P., Harmat, V., Kocsis, A., Bián, T., Barna, L., Ambrus, G., Végh, B. M., Balczer, J., Sim, R. B., Náray‐Szabó, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506051200 · Cited by 105
Ghannam, A., Pernollet, M., Fauquert, J., Monnier, N., Ponard, D., Villiers, M., Navarro, J., Tridon, A., Lunardi, J., Gerlier, D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5158 · Cited by 105
Ottonello, L. C., Corcione, A., Tortolina, G., Airoldi, I., Albesiano, E., Favre, A., D’Agostino, R., Malavasi, F., Pistoia, V., & Dallegri, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6510 · Cited by 103
Complement Factor H: A Biomarker for Progression of Cutaneous Squamous Cell Carcinoma
Riihilä, P., Nissinen, L. M., Ala‐aho, R., Kallajoki, M. A., Grenman, R. A., Meri, S., Peltonen, S. A., Peltonen, J. T. K., & Kähäri, V. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.346 · Cited by 103
Lalli, P. N., Strainic, M. G., Lin, F., Medof, M. E., & Heeger, P. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5793 · Cited by 103
Blanc, C., Roumenina, L. T., Ashraf, Y., Hyvärinen, S., Sethi, S. K., Ranchin, B., Niaudet, P., Loirat, C., Gulati, A., Bagga, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200679 · Cited by 102
Self-citationLoss of DGKε induces endothelial cell activation and death independently of complement activation
Bruneau, S., Néel, M., Roumenina, L. T., Frimat, M., Laurent, L., Frémeaux‐Bacchi, V., & Fakhouri, F. (2014) · Blood · doi:10.1182/blood-2014-06-579953 · Cited by 101
Self-citationClarke, E. V., Weist, B. M., Walsh, C., & Tenner, A. J. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0614-278r · Cited by 101
Mullmann, T. J., Siegel, M. I., Egan, R. W., & Billah, M. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1901 · Cited by 99
Role of the Mannose‐Binding Lectin in Innate Immunity
Ezekowitz, R. A. B. (2003) · The Journal of Infectious Diseases · doi:10.1086/374746 · Cited by 98
Lehtinen, M. J., Rops, A. L. W. M. M., Isenman, D. E., van der Vlag, J., & Jokiranta, T. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900814200 · Cited by 94
Pawluczkowycz, A. W., Lindorfer, M. A., Waitumbi, J. N., & Taylor, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5543 · Cited by 94
Immune modulation of human dendritic cells by complement
Castellano, G., Woltman, A. M., Schlagwein, N., Xu, W., Schena, F. P., Daha, M. R., & van Kooten, C. (2007) · European Journal of Immunology · doi:10.1002/eji.200636845 · Cited by 92
Characterization of Ehp, a Secreted Complement Inhibitory Protein from Staphylococcus aureus
Hammel, M., Sfyroera, G., Pyrpassopoulos, S., Ricklin, D., Ramyar, K. X., Pop, M., Jin, Z., Lambris, J. D., & Geisbrecht, B. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704247200 · Cited by 92
Toward a structure-based comprehension of the lectin pathway of complement
Kjær, T. R., Thiel, S., & Andersen, G. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.007 · Cited by 92
Ghannam, A., Fauquert, J., Thomas, C., Kemper, C., & Drouet, C. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.010 · Cited by 89
Cited by
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
Paczosa, M. K., & Mecsas, J. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00078-15 · Cited by 1,988
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Self-citationvan der Poll, T., Shankar-Hari, M., & Wiersinga, W. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.012 · Cited by 1,010
A dynamic COVID-19 immune signature includes associations with poor prognosis
Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946
Metadata
- Authors
- Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2015-05-26
- Volume
- 6
- Pages
- 257-257
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W1499593166
- Cited by
- 1,051
- References
- 280
- FWCI
- 28.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.